Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-χB and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity-Reference-Cited by-同舟云学术

Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-χB and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity

Published:1994-11 Issue:11 Volume:24 Page:2646-2652
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Jabado Nada,Le Deist Françoise,Fischer Alain,Hivroz Claire

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product.

2. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

3. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules

4. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling;Immunology Letters;2012-03

2. Anti-viral opportunities during transcriptional activation of latent HIV in the host chromatin;Methods;2011-01

3. Patterns of HIV-1 Protein Interaction Identify Perturbed Host-Cellular Subsystems;PLoS Computational Biology;2010-07-29

4. Recombinant Anti-CD4 Antibody 13B8.2 Blocks Membrane-Proximal Events by Excluding the Zap70 Molecule and Downstream Targets SLP-76, PLCγ1, and Vav-1 from the CD4-Segregated Brij 98 Detergent-Resistant Raft Domains;The Journal of Immunology;2007-06-19

5. In Vitro Antitumoral Activity of Baculovirus-expressed Chimeric Recombinant Anti-CD4 Antibody 13B8.2 on T-cell Lymphomas;Journal of Immunotherapy;2007-02